Molecular Markers in Cervical Cancer Screening in the Feasibility of the Mathematical Markov Model Analysis
The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2009 by Wuhan University.
Recruitment status was Not yet recruiting
Recruitment status was Not yet recruiting
Sponsor:
Wuhan University
Information provided by:
Wuhan University
ClinicalTrials.gov Identifier:
NCT00889902
First received: April 27, 2009
Last updated: NA
Last verified: April 2009
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to:
- make p16INK4A as a cervical cancer screening of tumor markers, cytology improve existing diagnostic sensitivity, specificity, repeatability and validity, so as to effectively prompted the early discovery and diagnosis of cervical cancer.
- reduce screening costs, screening and benefits into quantitative evaluation, for our country to develop cervical cancer prevention and control strategy to provide a reliable theoretical basis.
| Condition |
|---|
|
Cervical Cancer |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Prospective |
| Official Title: | Molecular Markers in Cervical Cancer Screening in the Feasibility of the Mathematical Markov Model Analysis |
Resource links provided by NLM:
Further study details as provided by Wuhan University:
Biospecimen Retention: Samples With DNA
Detailed Description:
Cervical exfoliated cells
| Estimated Enrollment: | 200 |
| Study Start Date: | April 2009 |
| Estimated Study Completion Date: | July 2011 |
| Estimated Primary Completion Date: | June 2010 (Final data collection date for primary outcome measure) |
- To carry out large-scale prospective randomized controlled clinical study to evaluate the "cytological molecular markers Detect + P16INK4A" methods of screening accuracy and reliability, as well as the screening method of the biological effects.
- Markov set up mathematical model of screening tests to quantify the inputs and the evaluation proceeds. With a view to optimize and perfect a simple, convenient, practical and efficient program of cervical cancer screening.
Eligibility| Ages Eligible for Study: | 25 Years to 65 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Probability Sample |
Study Population
residents of a certain town
Criteria
Inclusion Criteria:
- Married women aged 25 to 65-year-old with risk factors
- No tumor and pelvic radiation therapy history
- Non-pregnant women at present
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00889902
Contacts
| Contact: Hong B Cai, Doctor | 0086-027-67813044 | Chb2105@163.com |
| Contact: Ying J Huang |
Locations
| China, Hubei | |
| People'S Hospital | |
| Wufeng county, Hubei, China | |
Sponsors and Collaborators
Wuhan University
Investigators
| Study Director: | Hong B Cai, Doctor | gynecologic oncology department, Zhongnan Hospital of Wuhan University |
More Information
No publications provided
| Responsible Party: | HB Cai, Wuhan University |
| ClinicalTrials.gov Identifier: | NCT00889902 History of Changes |
| Other Study ID Numbers: | 320.6740 |
| Study First Received: | April 27, 2009 |
| Last Updated: | April 27, 2009 |
| Health Authority: | China: Ethics Committee |
Keywords provided by Wuhan University:
|
Molecular Markers Cervical Cancer Screening Makov |
Additional relevant MeSH terms:
|
Uterine Cervical Neoplasms Uterine Neoplasms Genital Neoplasms, Female Urogenital Neoplasms Neoplasms by Site |
Neoplasms Uterine Cervical Diseases Uterine Diseases Genital Diseases, Female |
ClinicalTrials.gov processed this record on June 13, 2013